4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001144204-10-036315
Options or other derivatives
- Chief Financial Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Plotts Thomas · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2010-06-30 | Grant or award : show line 1 in the form Options to Purchase Common Stock | +250,000 | 250,000 | D |
Loading xslF345X03/v189779_ex.xml…